• PCN216 Association of Patient Activation with the Health-Related Quality of Life of Patients with Pancreatic Cancer (PwPC)

    Jun 1, 2021, 00:00

  • PND33 A Cost-Effectiveness Analysis of Fenfluramine for the Treatment of Seizures for Patients with Dravet Syndrome (DS) in the UK Setting

    Jun 1, 2021, 00:00

  • Rare Orphan Diseases - Clinical Outcomes

    Jun 1, 2021, 00:00

  • Cardiovascular Disorders - Methodological Statistical Research

    Jun 1, 2021, 00:00

  • PGI7 Correlation between Clinical Outcomes and HTA Decisions in Ulcerative Colitis

    Jun 1, 2021, 00:00

  • Systemic Disorders/Conditions - Real World Data Information Systems

    Jun 1, 2021, 00:00

  • PNS111 Development of the SF-6DV2 Health Utility Survey: Content Validity and Patient Preference

    Jun 1, 2021, 00:00

  • PCN117 Immune-related adverse events (irAEs) in NSCLC patients treated with programmed cell death 1 (PD-1) inhibitors: An analysis using the data from FDA adverse event reporting system (FAERS)

    Jun 1, 2021, 00:00

  • PNS4 The Consequences of Greater Net Price Transparency for Innovative Medicines: Insights from European Experts and Payers

    Jun 1, 2021, 00:00

  • PCN174 Innovative Approaches to Cancer Therapy Provision in the COVID-Era

    Jun 1, 2021, 00:00

  • PND38 IMPACT of Remoteness on Cost of Illness of Australians with Multiple Sclerosis

    Jun 1, 2021, 00:00

  • PMH40 Effects of AXS-05 on Patient Reported Depressive Symptoms in Major Depressive Disorder: Results from the GEMINI Trial

    Jun 1, 2021, 00:00

  • PCN27 Real-World Characteristics and Outcomes of Patients with Metastatic Ductal Adenocarcinoma (MPDAC) Treated with Liposomal Irinotecan-Based Regimens By Race

    Jun 1, 2021, 00:00

  • PND29 Scenario Analyses on Major Impactful and Uncertain Inputs of the Cost-Effectiveness Model of Fremanezumab From a Healthcare System Perspective in England

    Jun 1, 2021, 00:00

  • Rare Process of Care

    Jun 1, 2021, 00:00

  • PCN176 A Multinational Comparison of HTA Decisions for New Treatment Options in Oncology in 2020

    Jun 1, 2021, 00:00

  • PCN61 Targeted Literature Review (TLR) of the Economic Burden and Cost-Effectiveness of Treatments for Advanced/Metastatic Melanoma

    Jun 1, 2021, 00:00

  • PCN201 Anonymous Online Cannabis Survey Captures Representative National Sample of People with Breast Cancer

    Jun 1, 2021, 00:00

  • PNS63 A Longitudinal Study to Identify Potentially Low-Value Clinical Procedures Using Hospital Episode Statistics Linked to Deprivation and Ethnicity in England, 2014/15-2018/19

    Jun 1, 2021, 00:00

  • PCN51 Annual Healthcare Resource Utilization and Costs in U.S. Patients Diagnosed with Relapsed Acute Myeloid Leukemia

    Jun 1, 2021, 00:00

  • PNS77 Transferring Health Technology Assessments from EARLY Adopter to Late Adopter Countries: Recommendations for the Implementation of CED Schemes in Central and Eastern European Countries

    Jun 1, 2021, 00:00

  • PMS29 Qualitative Study to Understand the Patient Experience of Knee Osteoarthritis (OA) and Assess the Content Validity of the Knee Injury and Osteoarthritis Outcome Score (KOOS) and HIP Disability and Osteoarthritis Outcome Score (HOOS) M ...

    Jun 1, 2021, 00:00

  • Disclosure Information

    Jun 1, 2021, 00:00

  • PSS3 Topline Patient-Reported Outcome Results from a Multicenter, Open-Label, Phase 4 Study of Repository Corticotropin Injection in Patients with Refractory Severe Noninfectious Keratitis

    Jun 1, 2021, 00:00

  • PNS6 Saving Lives or the Environment - How about Both? the Role of Health Technology Assessment (HTA) Bodies in Creating Sustainable Healthcare Systems

    Jun 1, 2021, 00:00

  • PMH49 Factors Affecting Medication Nonadherence Among Patients with Psychiatric Illness in Tertiary Care Teaching Hospital in South India

    Jun 1, 2021, 00:00

  • PND15 Health Care Resource Utilization and Costs Among Patients with Essential Tremor: A Retrospective Observational Study in a United States Commercially Insured and Medicare Advantage Population

    Jun 1, 2021, 00:00

  • PRS24 Utilizing Blue Cross Blue Shield of Louisiana (BCBSLA) Risk of Hospitalization (ROH) AI Predictive Model to Help Louisiana Identify Patients at High Risk for a COVID-19 Hospital Admission

    Jun 1, 2021, 00:00

  • PNS67 Gaining Trust in the Use of Virtual Meetings for Health Technology Assessment during the COVID-19 Pandemic

    Jun 1, 2021, 00:00

  • PCN245 Examining Longitudinal Practice Patterns in the use of ANTI-PD-1 and ANTI-PD-L1 Inhibitors as First-Line Therapy in Non-Small Cell Lung Cancer Patients in the US

    Jun 1, 2021, 00:00

  • PIN28 A US Payer Cost-Effectiveness Analysis of Imipenem/Cilastatin/Relebactam Versus Colistin Plus Imipenem/Cilastatin in Patients with Carbapenem-Resistant Bacterial Infections

    Jun 1, 2021, 00:00

  • PDB11 Real-world cost-effectiveness of SGLT-2 inhibitors versus DPP-4 inhibitors for type 2 diabetes: A modeling study

    Jun 1, 2021, 00:00

  • Economic Evaluation Applications: Burden and Value of Therapies

    Jun 1, 2021, 00:00

  • Infectious Diseases - Conceptual Papers (CP)

    Jun 1, 2021, 00:00

  • CE3 Systematic Review and Indirect Comparison of PD-(L)1 Inhibitors in Combination with Platinum-Based Doublet Chemotherapy (PT-DC) for the First-Line Treatment of Non-Squamous, Non-Small-Cell Lung Cancer (nsqNSCLC)

    Jun 1, 2021, 00:00

  • Drugs Statistical Research

    Jun 1, 2021, 00:00

  • Medical Devices - Economic Evaluation

    Jun 1, 2021, 00:00

  • PMU4 Bridging the Gap: Aligning Economic Research With Disease Burden

    Jun 1, 2021, 00:00

  • PNS99 Using an Online Survey to Elicit Preferences in China: Comparison of Different Methods Based on SF-6DV2

    Jun 1, 2021, 00:00

  • PCN67 Estimating Cost-Effectiveness of Pembrolizumab in Advanced Esophageal Cancer Based on the Keynote-181 Trial

    Jun 1, 2021, 00:00

  • PSY13 Relationship between Affected Body Surface Area and Initiation of Systemic Therapy in Psoriasis Patients

    Jun 1, 2021, 00:00

  • PCN53 Grade 3/4 Adverse Event (AE) Costs of Nivolumab Plus Ipilimumab (N+I) Versus Nivolumab Plus Cabozantinib (N+C) and Pembrolizumab Plus Axitinib (P+A) for Previously Untreated Advanced Renal Cell Carcinoma (aRCC)

    Jun 1, 2021, 00:00

  • PRO8 Effectiveness and Safety of Teriflunomide in Patients with Multiple Sclerosis: A Real-World Study from WEST China Hospital, China

    Jun 1, 2021, 00:00

  • PDB27 An Evaluation of the Use of Psychotropic Agents Among Adults 65 Years or Older with Type 2 Diabetes

    Jun 1, 2021, 00:00

  • PUK19 DATA Quality Considerations for Determining the IMPACT of the COVID-19 Pandemic on Outpatient Visits and Procedures in the United States

    Jun 1, 2021, 00:00

  • PCN19 Beyond a Binary Endpoint: Longitudinal and Individual Symptom Analyses from the Simplify-1 Study Demonstrate Clinically Comparable Symptomatic Benefit of Momelotinib to Ruxolitinib in JAK Inhibitor Naive Myelofibrosis Patients

    Jun 1, 2021, 00:00

  • PNS101 Evaluation of Artificial Intelligence within DistillerSR Software As a Second Reviewer for a Systematic Literature Review

    Jun 1, 2021, 00:00

  • PIN74 Health-Related Quality of Life (HRQoL) in COVID-19 Patients - a Systematic Literature Review

    Jun 1, 2021, 00:00

  • PGI8 An Exploratory Analysis of the Survival Benefits in Commercially Insured Patients with Hepatic Encephalopathy (HE) Treated with Rifaximin versus Lactulose Alone using US Claims Data

    Jun 1, 2021, 00:00

  • Factors Associated With Generic Drug Uptake in the United States, 2012 to 2017

    Jun 1, 2021, 00:00

  • PSS12 Understanding the Patient Experience with Anti-VEGF Intravitreal Injections and the Impact on Treatment Maintenan A Qualitative Interview Study

    Jun 1, 2021, 00:00

  • PND2 Efficacy and Safety of Disease-Modifying Therapies for the Treatment of Relapsing-Remitting Multiple Sclerosis: A Systematic Review

    Jun 1, 2021, 00:00

  • Biologics/Biosimilars/Regenerative Medicine - Health Technology Assessment

    Jun 1, 2021, 00:00

  • PNS79 Milestones for HTA Institutionalization in Ukraine Due to International Practice

    Jun 1, 2021, 00:00

  • PCV30 Framing Effect of Willingness to Pay for Salt Reduction in Hypertensive Patients

    Jun 1, 2021, 00:00

  • PSS8 The Economic Burden of Macular Edema (ME) Associated with Non-infectious Uveitis (NIU) – A US Commercial Payer’s Perspective

    Jun 1, 2021, 00:00

  • PDB12 Hospital Burden of Chronic Gout with and without Tophus Insured By Medicaid: A Propensity Score Matched Analysis of in-Patient Claims Database

    Jun 1, 2021, 00:00

  • PMS33 Long- and Short-Term Disability and Workers' Compensation Trends for Employees with Systemic Lupus Erythematosus or Connective Tissue Disorders in the United States

    Jun 1, 2021, 00:00

  • Infectious Diseases - Organizational Practices

    Jun 1, 2021, 00:00

  • Urinary/Kidney Disorders - Real World Data Information Systems

    Jun 1, 2021, 00:00

  • PCN83 Healthcare Resource Utilization (HCRU) of Patients with Resected Esophageal Cancer or Gastroesophageal Junction Cancer (EC/GEJC) Receiving Adjuvant Nivolumab Treatment Versus Placebo:

    Jun 1, 2021, 00:00

  • PRO4 Uncertainty in Clinical Outcomes in the Treatment of Paediatric Orphan Indications with Licensed Therapies

    Jun 1, 2021, 00:00

  • PSY22 A Systematic Literature Review of the Relationship Between Serum Ferritin and Outcomes on Myelodysplastic Syndromes

    Jun 1, 2021, 00:00

  • PCN220 Conceptual Framework of Symptoms and Impacts Experienced By Patients with Nut Carcinoma

    Jun 1, 2021, 00:00

  • PDG19 Prescription Opioid Use in Women during Pregnancy - A Retrospective Analysis Using Texas Medicaid Prescription Claims Data

    Jun 1, 2021, 00:00

  • PMU36 Effects of the Medicare PART D Comprehensive Medication Review on Medication Adherence Among Beneficiaries with Alzheimer's Disease

    Jun 1, 2021, 00:00

  • PIN57 Role of Pharmacists in Blood-Borne Pathogen Prevention through Needle/Syringe Services: A Case Study of Community Pharmacists in Alabama

    Jun 1, 2021, 00:00

  • PDB43 eHealth Use Among Type 2 Diabetics: PRE-COVID Associations with Patient Activation, Preventive Behaviors, and Health Outcomes

    Jun 1, 2021, 00:00

  • RE2 Modeling the Impact of Drug Pricing Policies on Innovation

    Jun 1, 2021, 00:00

  • PRO23 An Observational Cohort Analysis on the Economic IMPACT of Chronic Kidney Disease in Patients with Fabry Disease

    Jun 1, 2021, 00:00

  • PRS36 Use of Logistic Lasso Regression to Predict Treatment Adherence Among Medicare Beneficiaries with COPD

    Jun 1, 2021, 00:00

  • PCN94 Budget IMPACT of Changing Nivolumabe Doses: A Simulation in Health Insurance System

    Jun 1, 2021, 00:00

  • PUK8 Water: A Prevention Strategy to Decrease the Economic Burden of Recurrent Cystitis Among Women in the United States of America

    Jun 1, 2021, 00:00

  • PCN137 Measuring Driving Access to Genetic Counselors and Examining Equity of Coverage

    Jun 1, 2021, 00:00

  • PCN46 Economic Evaluation of Esophageal Cancer Screening Among Patients with Oral Cavity Cancer in Taiwan

    Jun 1, 2021, 00:00

  • PDG5 Changes in Canadian Guidelines for Conducting Budget IMPACT Analysis

    Jun 1, 2021, 00:00

  • PCN172 Evaluation of Real-World Evidence (RWE) Used within Health Technology Assessments (HTA) in Oncology with Pivotal Single-Arm Trials: A Comparative Study of Six HTA Agencies

    Jun 1, 2021, 00:00

  • PCN113 Prevalence of MET exon 14 (METex14) Skipping in Patients with Advanced NSCLC: A Systematic Literature Review

    Jun 1, 2021, 00:00

  • PNS57 Impacts of Income Resources on Informal Care Usage in England

    Jun 1, 2021, 00:00

  • PNS42 The Financial Burden of Medicine out of Pocket Payment Among Households in Ethiopia: An Analysis of Trends and Determinants

    Jun 1, 2021, 00:00

  • PRO61 Health-Related Quality of Life (HRQOL) and Healthcare Resource Use (HCRU) Associated with the Treatment of Pompe Disease (PD): Targeted Literature Reviews

    Jun 1, 2021, 00:00

  • PDB17 TOTAL Cost of Care and Utilization Among Medicare Fee-for-Service (FFS) Patients with Metastatic Pancreatic Cancer Treated with FDA-Approved/NCCN® Category 1 Regimens at 340B VS. NON-340B Hospitals

    Jun 1, 2021, 00:00

  • PSU18 Exploring Cumulative SUM (CUSUM) As a Method to Evaluate Change in Operating Room Time in the Initial Cases of a Surgeon Using Robotic Assisted Surgery (RAS)

    Jun 1, 2021, 00:00

  • Cardiovascular Disorders - Clinical Outcomes

    Jun 1, 2021, 00:00

  • PSS11 Comparing Patient's Compliance and Persistence on Prostaglandin Analogs Using Real-World Utilization Databases for the Treatment of OPEN-Angle Glaucoma or Ocular Hypertension.

    Jun 1, 2021, 00:00

  • PIN66 Validating an Agent-Based Simulation Model of Hospital-Acquired Clostridioides Difficile Infection Using Primary Hospital Data

    Jun 1, 2021, 00:00

  • PCN21 A Real-World Assessment of the Treatment Patterns, Healthcare Resource Utilization (HCRU) and Outcomes Associated with Gastric Cancer (GC) and Gastroesophageal Junction Cancer (GEJC) in the United States

    Jun 1, 2021, 00:00

  • PCN236 A Retrospective Real-World Evidence Study of Patients with Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETS) in the US Using the Optum Database

    Jun 1, 2021, 00:00

  • PIH40 Screen-Based Media Use among Children and Adolescents: An Application of Unsupervised Topic Modeling

    Jun 1, 2021, 00:00

  • PRO17 Cost-Minimization Analysis of Lanreotide Autogel Versus Octreotide LAR in Patients with Acromegaly in the Brazilian Public Health System

    Jun 1, 2021, 00:00

  • PNS16 Capturing the Complexity of Medicare's Pharmacy Benefit Structure in a Budget Impact Model

    Jun 1, 2021, 00:00

  • CN4 Patient-Reported Outcomes from the Phase 3, Randomized Study of Acalabrutinib with or without Obinutuzumab Versus Chlorambucil PLUS Obinutuzumab for Treatment-Naïve Chronic Lymphocytic Leukemia (ELEVATE-TN)

    Jun 1, 2021, 00:00

  • PIN5 Immunogenicity and Safety of the COVID-19 Vaccines Compared to Controls in Healthy Adults: A Systematic Review

    Jun 1, 2021, 00:00

  • PCN233 Concordance of Clinical Vs. Algorithm Based Line of Therapy Determination in Lung Cancer

    Jun 1, 2021, 00:00

  • PCN60 Healthcare Resource Utilization Burden in the Management of Triple-Class Exposed Patients With Relapsed/Refractory Multiple Myeloma: Results From the ITEMISE Study

    Jun 1, 2021, 00:00

  • Infectious Diseases - Clinical Outcomes

    Jun 1, 2021, 00:00

  • PUK9 Economic Evaluation of Prostate-Specific Antigen Screening for Prostate Cancer in China

    Jun 1, 2021, 00:00

  • Mental Health - Medical Technologies

    Jun 1, 2021, 00:00

  • PIH7 Cost-Effectiveness of a Proteomic Test for Preterm Birth Prediction

    Jun 1, 2021, 00:00

  • Respiratory-Related Disorders - Real World Data Information Systems

    Jun 1, 2021, 00:00

  • PDG41 Evaluating the Effectiveness and Safety and Economy of Domestic and Original Tigecycline for Injection in Real-World Based on PSM Method

    Jun 1, 2021, 00:00

  • PRO69 Real-World Treatments and Health-Related Quality of Life in Patients with Prurigo Nodularis in the Lotus PN Observational Trial

    Jun 1, 2021, 00:00

  • Gastrointestinal Disorders - Epidemiology Public Health

    Jun 1, 2021, 00:00

  • Respiratory-Related Disorders - Methodological Statistical Research

    Jun 1, 2021, 00:00

  • Early Cost-Effectiveness of Onasemnogene Abeparvovec-xioi (Zolgensma) and Nusinersen (Spinraza) Treatment for Spinal Muscular Atrophy I in The Netherlands With Relapse Scenarios

    Jun 1, 2021, 00:00

  • PMD3 The Current Burden of Cataract Surgery and Outcomes of Image-Guided Systems: A Targeted Literature Review

    Jun 1, 2021, 00:00

  • PMU41 Clinical Pharmacy Provider Dashboards May Prevent Avoidable Adverse Events and Reduce Total Cost of Care

    Jun 1, 2021, 00:00

  • PMU13 Economic Impact of Comorbidities in an Employer-Insured Migraine Population

    Jun 1, 2021, 00:00

  • PCN151 The Geographical Association with LUNG Cancer Incidents, Mortality, and Accessibility of LUNG Cancer Screening in RURAL Appalachia

    Jun 1, 2021, 00:00

  • PMH12 To Evaluate the Overall Clinical and Economic Burden of Treatment Resistant Depression in Egypt from the Payers Perspective

    Jun 1, 2021, 00:00

  • EM4 Recommendations for Handling Uncertainty in Economic Evaluation: A Targeted Review of Pharmacoeconomic Guidelines

    Jun 1, 2021, 00:00

  • PRO66 Health-Related Quality of Life in Persons with Sickle Cell Disease

    Jun 1, 2021, 00:00

  • PIH15 Antimuscarinic Cascade across Individual Cholinesterase Inhibitors in Older Adults with Dementia

    Jun 1, 2021, 00:00

  • Neurological Disorders - Methodological Statistical Research

    Jun 1, 2021, 00:00

  • PCN162 Real-World Biomarker Testing Rates in Metastatic Colorectal Cancer in the United States

    Jun 1, 2021, 00:00

  • Alternative Medicine Public Health

    Jun 1, 2021, 00:00

  • PCN194 Comparing Complex Machine Learning Models to Predict Likelihood of Ovarian Cancer Using Medicare Claims DATA

    Jun 1, 2021, 00:00

  • PCN99 Healthcare Costs for Elderly Patients with Lung Cancer and Comorbid Major Depressive Disorder (MDD)

    Jun 1, 2021, 00:00

  • PRO24 Healthcare Utilization and Costs Among Patients Diagnosed with Sickle Cell Disease Enrolled in Mississippi Medicaid

    Jun 1, 2021, 00:00

  • PMU59 Predictors and Health Related Quality of Life Associated with Renal Diseases in Cancer Patients in United States

    Jun 1, 2021, 00:00

  • Individual's Health - Patient-Centered Research

    Jun 1, 2021, 00:00

  • PCN146 Association of Health Related Quality of Life with Breast Cancer Survival Among Hispanic Population Using Medical Expenditure Panel Survey DATA (2006-2015)

    Jun 1, 2021, 00:00

  • PMD4 Patient-Specific Factors Impacting the Reduction in Pain or Pain Medication Utilization After Treatment with Intra-Articular Hyaluronic Acid in Knee Osteoarthritis: A Retrospective Cohort Study

    Jun 1, 2021, 00:00

  • PCN244 Supervised Machine Learning for Predicting Mortality in Acute Myeloid Leukemia Patients Using Electronic Health Record Data

    Jun 1, 2021, 00:00

  • EC4 Real-World Healthcare Costs in Patients with Classical Hodgkin Lymphoma Treated with Pembrolizumab and Nivolumab in the United States

    Jun 1, 2021, 00:00

  • PUK11 Comparison of Hospitalization Burden of Hyperkalemia in Medicaid Patients By Ethnicity: A Propensity Score Matched Analysis of in-Patient Claims Database

    Jun 1, 2021, 00:00

  • Neurological Disorders - Organizational Practices

    Jun 1, 2021, 00:00

  • Economic Evaluation of New Models of Care: Does the Decision Change Between Cost-Utility Analysis and Multi-Criteria Decision Analysis?

    Jun 1, 2021, 00:00

  • Musculoskeletal Disorders - Clinical Outcomes

    Jun 1, 2021, 00:00

  • Multiple Diseases - Organizational Practices

    Jun 1, 2021, 00:00

  • PND36 Budget Impact Analysis of the Incorporation of Mechanical Thrombectomy with Stent Retrievers after Thrombolysis in Ischemic-Stroke with Large Vessel Occlusion in Programa De Atencion medica Integral Pami in Argentina

    Jun 1, 2021, 00:00

  • PCN205 IMPACT of Treatment Adherence on CORE Outcomes in Patients with Colorectal Cancer: A Systematic Review

    Jun 1, 2021, 00:00

  • PMU38 Market Access Trends of Pharmaceutical Products in the EU5 and US (2009-2019)

    Jun 1, 2021, 00:00

  • PIN49 Developing a Predictive Algorithm to Identify the Key Factors Impacting on the Transmission and Fatalities from COVID-19

    Jun 1, 2021, 00:00

  • PNS104 Findings from the 2020 Ispor Student Benefit Survey

    Jun 1, 2021, 00:00

  • Mental Health - Real World Data Information Systems

    Jun 1, 2021, 00:00

  • PNS17 Value of a Comprehensive Ophthalmology Custom Pack in a Canadian Setting

    Jun 1, 2021, 00:00

  • PMU64 Impact Of The First Demonstration of a Patient-Centered Medical Home (PCMH) In Singapore On Quality Of Life And Patient Activation In Older Adults

    Jun 1, 2021, 00:00

  • PIH36 How Does Caregiver Burden Change As Alzheimer's Dementia (AD) Severity Advances?

    Jun 1, 2021, 00:00

  • Surgery - Real World Data Information Systems

    Jun 1, 2021, 00:00

  • PCN71 Treatment-Related Costs of Pharmacologic Regimens for Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma (R/R DLBCL) Who Have Received Two or More Prior Lines of Therapies

    Jun 1, 2021, 00:00

  • Sensory System Disorders - Real World Data Information Systems

    Jun 1, 2021, 00:00

  • PSS17 Long- and Short-Term Disability and Workers' Compensation Trends for Employees with Eye (Ophthalmic) Conditions in the United States

    Jun 1, 2021, 00:00

  • PRS15 A Cost-Utility Analysis of Dacomitinib As First-Line Treatment for Patients with Locally Advanced or Metastatic Non-Small Cell Lung Cancer with EGFR Exon 21 L858R Substitution Mutation in China

    Jun 1, 2021, 00:00

  • Medical Technology Studies

    Jun 1, 2021, 00:00

  • PRS3 Joint Modelling of Forced Vital Capacity Decline and Time to Hospitalization Outcomes in Systemic Sclerosis-Associated Interstitial Lung Disease

    Jun 1, 2021, 00:00

  • PMU5 IMPACT of Telehealth Utilization during the COVID-19 Pandemic on Health Care Resource Utilization

    Jun 1, 2021, 00:00

  • PIN43 Sociodemographic Characteristics Associated with Vaccination for Dengue Fever and Yellow Fever in Brazil: Results from the 2018 National Health and Wellness Survey

    Jun 1, 2021, 00:00

  • Cancer - Health Technology Assessment

    Jun 1, 2021, 00:00

  • Medical Devices - Medical Technologies

    Jun 1, 2021, 00:00

  • PCN182 A Partial Mcda Approach to Identify Key Criteria for Brazilian Public Reimbursement Decision in Melanoma Adjuvant Treatment Setting

    Jun 1, 2021, 00:00

  • PNS9 Estimating Incidence Progressed Patients in Partitioned Survival Models - a Comparison of Three Methodologies

    Jun 1, 2021, 00:00

  • Respiratory-Related Disorders - Patient-Centered Research

    Jun 1, 2021, 00:00

  • PND22 Cost-Utility of Mechanical Thrombectomy after Thrombolysis in Ischemic-Stroke Due to Large Vessel Oclussion in Obras Sociales and Empresas De Medicina Prepaga in Argentina

    Jun 1, 2021, 00:00

  • Musculoskeletal Disorders - Epidemiology Public Health

    Jun 1, 2021, 00:00

  • PIN67 Real-Time Analysis of COVID-19 DATA Using Sequential Monte Carlo Methods

    Jun 1, 2021, 00:00

  • PCN232 Economic Burden Among Breast Cancer Patients in the United States

    Jun 1, 2021, 00:00

  • PCN184 Understanding the VALUE of Real-World Evidence (RWE) in Health Economics: Are Traditional Systematic Literature Reviews (SLRS) Omitting Key Evidence for Health Technology Assessment (HTA)?

    Jun 1, 2021, 00:00

  • PDG27 A Systematic Review of Concomitant Opioid and Sedative or Skeletal Muscle Relaxant Use on Patient Outcomes in Chronic Non-Malignant Pain

    Jun 1, 2021, 00:00

  • PCN7 Analysis of Individual-Level Association of Progression-Free Survival (PFS) and Time to Treatment Failure (TTF) with Overall Survival (OS) for Previously Untreated Advanced Renal Cell Carcinoma Patients in the CheckMate 214 Trial

    Jun 1, 2021, 00:00

  • PRO73 Limitations of Matched Control Groups Using Stabilization Criteria: A Case Study in CAH

    Jun 1, 2021, 00:00

  • PIN35 Prevalence of COVID-19 vs. Seasonal Influenza: A Population-Based National Survey of US Adults

    Jun 1, 2021, 00:00

  • Cardiovascular Disorders - Economic Evaluation

    Jun 1, 2021, 00:00

  • PMD2 Laparoscopic Radiofrequency Ablation VS Laparoscopic Myomectomy in the Treatment of Symptomatic Uterine Leiomyomas: A Meta-Analysis of Randomized Controlled Trials

    Jun 1, 2021, 00:00

  • PMU8 The Economic Burden of Thromboembolic Events Among Patients with Immune-Mediated Diseases

    Jun 1, 2021, 00:00

  • PND7 Assessing the Comparative Efficacy of INP104 for Acute Treatment of Migraine Attacks: A Matching-Adjusted Indirect Comparison

    Jun 1, 2021, 00:00

  • PMS23 Preferences of Patients with Rheumatoid Arthritis Are Diverse and Changeable

    Jun 1, 2021, 00:00

  • Infectious Diseases - Methodological Statistical Research

    Jun 1, 2021, 00:00

  • Cancer - Medical Technologies

    Jun 1, 2021, 00:00

  • PNS2 Does the Type of Device Affect Usability or Conceptual Understanding of Patient-Reported Outcomes? Qualitative Evidence and Implications for Bring-Your-Own-Device (BYOD)

    Jun 1, 2021, 00:00

  • MT3 Assessing the Potential Value of Wearable Digital Health Technologies in Chronic Kidney Disease Using Early HTA Methods

    Jun 1, 2021, 00:00

  • AI4 Comparing Machine-Learning Methods for the Prediction of Major Adverse Limb Events and Mortality after a Percutaneous Intervention

    Jun 1, 2021, 00:00

  • PCN136 Evaluation of the Extent of Real-World Evidence (RWE) Used Within Health Technology Appraisals (HTA) in Oncology: A Comparative Study of Six HTA Agencies

    Jun 1, 2021, 00:00

  • Diabetes/Endocrine/Metabolic Disorders - Health Policy Regulatory

    Jun 1, 2021, 00:00

  • PMS3 Risk Factors Associated with Falls and Fractures Followed by Opioid Prescription among Privately-Insured Patients with Osteoarthritis

    Jun 1, 2021, 00:00

  • PRS14 Evolution of Direct Medical Costs Associated with Respiratory Syncytial VIRUS Disease in Infants: A Retrospective Database Analysis from 2008 to 2017

    Jun 1, 2021, 00:00

  • PNS118 Real World Evidence (RWE) Use in Latin America Healthcare Decision Making: An Stakeholder Survey Analysis.

    Jun 1, 2021, 00:00

  • PNS45 Pricing and Reimbursement of Innovative Medicines: Challenges and Lessons from South-Eastern Europe

    Jun 1, 2021, 00:00

  • Urinary/Kidney Disorders - Economic Evaluation

    Jun 1, 2021, 00:00

  • PCV14 Examining the Direct and Indirect Healthcare Cost Among Pulmonary Arterial Hypertension Patients

    Jun 1, 2021, 00:00

  • PCV48 Clinical Restrictions in Cardiac Health Technology Assessments

    Jun 1, 2021, 00:00

  • PCN193 Assessing the Impact of Modeling Non-Disease-Related Mortality on Long-Term Survivorship Rates in Previously Untreated Advanced Melanoma: A Case Study from CheckMate 067

    Jun 1, 2021, 00:00

  • PRO28 Healthcare Resource Use (HCRU) of Patients with Aromatic L-Amino Acid Decarboxylase Deficiency (AADC-D) in France

    Jun 1, 2021, 00:00

  • Urinary/Kidney Disorders - Methodological Statistical Research

    Jun 1, 2021, 00:00

  • PCN109 Disease Burden of Metastatic Hormone-Sensitive Prostate Cancer (MHSPC) in China

    Jun 1, 2021, 00:00

  • PBI13 Cost-Minimization Analysis and Budget Impact of Upadacitinib in the Treatment of Rheumatoid Arthritis in the Brazilian Public Health System

    Jun 1, 2021, 00:00

  • PCN107 Economic Burden of Complications Associated with Transthoracic Needle Biopsy of Pulmonary Nodules: A Retrospective Cohort Analysis

    Jun 1, 2021, 00:00

  • PIH25 Comparative Effectiveness Analysis of a Pediatric Co-Management Program

    Jun 1, 2021, 00:00

  • PR2 Concordance of Preferences and Treatment Choice Using Choice Based Adaptive Conjoint Analysis

    Jun 1, 2021, 00:00

  • IN2 Characteristics of Patients Diagnosed with Coronavirus Disease 2019 (COVID-19) across the Three Waves in the US: A Claims-Based Study Using a Large National Sample

    Jun 1, 2021, 00:00

  • IN3 Economic VALUE and Health System IMPACT of Remdesivir in Treating Hospitalized COVID-19 Patients in the United States

    Jun 1, 2021, 00:00

  • Mental Health - Methodological Statistical Research

    Jun 1, 2021, 00:00

  • Neurological Disorders - Real World Data Information Systems

    Jun 1, 2021, 00:00

  • PCV31 Cost-Effectiveness of Dronedarone for the Treatment of Atrial Fibrillation in China

    Jun 1, 2021, 00:00

  • PND54 A Comparison of NOS and ROBINS-I Tools for Quality Assessment of Observational Studies

    Jun 1, 2021, 00:00

  • PIN21 The Cost-Utility of Remote Pulse-Oximeter Monitoring of COVID19 Patients

    Jun 1, 2021, 00:00

  • ED4 Economic Burden of Attention-Deficit/Hyperactivity Disorder (ADHD) Among Children and Adolescents in the United States (US): A Societal Perspective

    Jun 1, 2021, 00:00

  • PUK10 Cost–Utility Analysis of DyeVert Contrast Reduction Systems for Preventing Contrast-Induced Acute Kidney Injury in Patients Undergoing Coronary and/or Peripheral Angiography

    Jun 1, 2021, 00:00

  • Drugs Generics - Health Technology Assessment

    Jun 1, 2021, 00:00

  • PRO35 Characterization and Treatment of Immune Thrombocytopenia (ITP) in Europe: A Qualitative Observational Study

    Jun 1, 2021, 00:00

  • Infectious Diseases - Economic Evaluation

    Jun 1, 2021, 00:00

  • PCN211 Health-Related Quality of Life in DLBCL Patients Treated with CAR T-Cell Therapy:

    Jun 1, 2021, 00:00

  • PNS22 Real-World DATA of ADR Reports in Signal Detection - DME Perspective

    Jun 1, 2021, 00:00

  • PMS26 Decision-Making and Experienced Benefits and Risks of Corticosteroids As a Treatment for Duchenne Muscular Dystrophy

    Jun 1, 2021, 00:00

  • PRO56 Psychometric Validation of the Short-Form 36 (version 2) (SF-36) in Tumor-Induced Osteomalacia (TIO)

    Jun 1, 2021, 00:00

  • PMU31 An Assessment of the Relationship Between Depression and Treatment Satisfaction Among Saudi Acne Vulgaris Patients Using Expectation–Confirmation Theory

    Jun 1, 2021, 00:00

  • PRO21 Burden of Illness in Patients with Light Chain (AL) Amyloidosis: A Real World Study Using Optum Claims Database

    Jun 1, 2021, 00:00

  • PND61 Caregiver-Reported Outcomes in Alzheimer's Disease and Other Dementias: A Survey of Interventional Clinical Trials of Pharmacologic Therapies

    Jun 1, 2021, 00:00

  • PMU25 Computable Phenotypes (CPS) for Identifying Individuals with MULTI-Morbidity from Real-World DATA (RWD): A Systematic Literature Review

    Jun 1, 2021, 00:00

  • PNS27 Amphetamine-Related Hospitalizations in the United States, 2003-2014: Examining Trends and Factors Associated with Admission Outcomes

    Jun 1, 2021, 00:00

  • PND63 Patient Utilities in Parkinson's Disease in Health States Based on Hoehn and Yahr and Off-Time

    Jun 1, 2021, 00:00

  • Neurological Disorders - Clinical Outcomes

    Jun 1, 2021, 00:00

  • Biologics/Biosimilars/Regenerative Medicine - Clinical Outcomes

    Jun 1, 2021, 00:00

  • PCN32 Comparative Efficacy of Combination of Dabrafenib and Trametinib Against Other Adjuvant Therapies for Melanoma

    Jun 1, 2021, 00:00

  • PRO48 Utilities in a rare disease collected via vignettes in general population samples from the UK and Fran comparison of Results

    Jun 1, 2021, 00:00

  • PCN237 Patterns of Healthcare Resource Utilization (HRU) in Unfit Patients with Acute Myeloid Leukemia (AML) Receiving First-line Systemic Treatment or Best Supportive Care (BSC): A Multicenter International Study (CURRENT)

    Jun 1, 2021, 00:00

  • PNS95 Valuation of Preference-Based Measures: Could Borrowing Strength from Existing Countries' Valuations Produce Better Estimates

    Jun 1, 2021, 00:00

  • PSU9 A Cost-Consequence MODEL of Surgical Nutrition for TOTAL Knee Arthroplasty

    Jun 1, 2021, 00:00

  • PSU6 Cost-Eectiveness Analysis of the Application of Porcine-Derived Fibrin Sealant for the Treatment of IntraOperative Cerebrospinal Fluid Leak in China

    Jun 1, 2021, 00:00

  • HT3 What is Value? A Systematic Review of Value Assessment Frameworks

    Jun 1, 2021, 00:00

  • PSU11 Resource Utilization and Disaggregated Cost Analysis of Bariatric Surgery in the Australian Public Healthcare System

    Jun 1, 2021, 00:00

  • PCN139 Value Frameworks and Innovative Contracting for Comprehensive Genomic Profiling

    Jun 1, 2021, 00:00

  • Does Cost-Effectiveness Analysis Overvalue Potential Cures? Exploring Alternative Methods for Applying a “Shared Savings” Approach to Cost Offsets [Editor's Choice]

    Jun 1, 2021, 00:00

  • No Specific Disease - Real World Data Information Systems

    Jun 1, 2021, 00:00

  • Surgery - Epidemiology Public Health

    Jun 1, 2021, 00:00

  • PCV22 Estimating the Reduction in Medical Care Costs Associated with Ticagrelor and Aspirin in Patients with Acute Ischemic Stroke or TIA

    Jun 1, 2021, 00:00

  • IN4 Non-Health Considerations in Economic Evaluations of COVID-19 Interventions: A Systemic Review

    Jun 1, 2021, 00:00

  • PCN12 A Systematic Literature Review (SLR) of Clinical Outcomes of Treatments for Adult and Pediatric Relapsed/Refractory (R/R) Classical Hodgkin's Lymphoma (cHL) Patients in the UK

    Jun 1, 2021, 00:00

  • PCN150 Barriers to and Facilitators of Cervical Cancer Screening Among Women in Southeast Asia: a Systematic Review

    Jun 1, 2021, 00:00

  • No Specific Disease - Patient-Centered Research

    Jun 1, 2021, 00:00

  • PCN231 Humanistic and Economic Burden in Patients with Chronic Myeloid Leukemia – A Review of the Literature

    Jun 1, 2021, 00:00

  • PRO18 A Systematic Literature Review of the Economic Burden and Cost Drivers in Pulmonary Arterial Hypertension

    Jun 1, 2021, 00:00

  • PRO47 Understanding the Burden of Long-Chain Fatty Acid Oxidation Disorders for Patients and Caregivers

    Jun 1, 2021, 00:00

  • Infectious Diseases - Health Technology Assessment

    Jun 1, 2021, 00:00

  • PCN15 Increasing Disease Complexity Poses Challenges for Indirect Treatment Comparisons: An Example in Relapsed and Refractory Multiple Myeloma (RRMM)

    Jun 1, 2021, 00:00

  • PRO29 Cost-Effectiveness Analysis of Using Hypoxic Stored Red Blood Cells to Reduce the Frequency of Blood Transfusions

    Jun 1, 2021, 00:00

  • PCN34 Comparative Effectiveness of Docetaxel and Paclitaxel in Advanced Esophageal Squamous Cell Carcinoma Refractory or Intolerant to Previous Chemotherapy: Propensity Score-Matching Analyses from Attraction-3 Trial

    Jun 1, 2021, 00:00

  • PGI3 A Network Meta-Analysis to Compare Efficacy of Filgotinib with Other Treatments in Biologic-Naïve Patients with Moderately to Severely Active Ulcerative Colitis

    Jun 1, 2021, 00:00

  • PCN82 Cost-Effectiveness of Once Weekly Selinexor-Bortezomib-Dexamethasone (XVD) in Previously Treated Multiple Myeloma (MM)

    Jun 1, 2021, 00:00

  • PMH19 Evaluation of Symptoms of Depression Amongst People with Substance Use during COVID-19 Lockdown in India: A CROSS-Sectional Study

    Jun 1, 2021, 00:00

  • PRO30 The Cost-Effectiveness of OTL-200 for the Treatment of Metachromatic Leukodystrophy (MLD)

    Jun 1, 2021, 00:00

  • PSY11 Systematic Literature Review to Assess Overall Costs and Societal Impacts of Atopic Dermatitis in Europe

    Jun 1, 2021, 00:00

  • Injury Trauma - Economic Evaluation

    Jun 1, 2021, 00:00

  • PCN52 Cost-Effectiveness Analysis of the Third-LINE Treatment of Regorafenib for Metastatic or Unresectable Gastrointestinal Stromal Tumors in China

    Jun 1, 2021, 00:00

  • PCV4 Comorbidities and Survival Risk Measures of Pulmonary Hypertension (PH) Patients in US-Clinical Care: Real-World Assessments from the Trio Health PH Registry

    Jun 1, 2021, 00:00

  • Systemic Disorders/Conditions - Patient-Centered Research

    Jun 1, 2021, 00:00

  • The Use of Decision Analytic Modeling in the Evaluation of Surgical Innovations: A Scoping Review

    Jun 1, 2021, 00:00

  • PCN202 Use of Restricted Mean Survival Time in the Presence of Non-Proportional Hazards As an Alternative Measure of Treatment Benefit in Cost-Effectiveness Analyses

    Jun 1, 2021, 00:00

  • Multiple Diseases - Patient-Centered Research

    Jun 1, 2021, 00:00

  • PND51 Trends and Characteristics in Opioid Analgesic Use for Migraine in US Emergency Departments: Analysis of National Hospital Ambulatory Medical Care Survey 2007-2018 Data

    Jun 1, 2021, 00:00

  • PRO65 Engaging Patients in Drug Development for Regulatory and HTA Decisions: A Case Study in Patients with Hidradenitis Suppurativa

    Jun 1, 2021, 00:00

  • PCN213 Systematic Literature Review to Characterize the Burden and Unmet Needs Associated with Cremophor EL

    Jun 1, 2021, 00:00

  • PIT4 In-HOME IV Antibiotics Cost and Utilization Following Tibia Fractures

    Jun 1, 2021, 00:00

  • CE2 Effect of Different Variance Estimation Methods with Inverse Probability Treatment Weights (IPTW) on Comparative Effectiveness Measure in Multiple Sclerosis

    Jun 1, 2021, 00:00

  • PNS52 Examining US Commercial Health Plans' Use of Step Therapy Protocols for Specialty Drugs: An Empirical Analysis

    Jun 1, 2021, 00:00

  • Machine Learning Applications in Health

    Jun 1, 2021, 00:00

  • PRO74 Pilot Study of a Novel Patient-facing Medical Records Collection Platform to Support Real World Data Generation in Rare Disease

    Jun 1, 2021, 00:00

  • Urinary/Kidney Disorders - Clinical Outcomes

    Jun 1, 2021, 00:00

  • PIN23 Costs-Consequences Analysis of Ceftaroline Fosamil for the Treatment of Community-Acquired Pneumonia in the Brazilian Private Healthcare System

    Jun 1, 2021, 00:00

  • PIN31 Budget-IMPACT Analysis of Letermovir for Preventing Cytomegalovirus in Adult Cytomegalovirus Seropositive Allogeneic Hematopoietic Cell Transplant Recipients in the United States

    Jun 1, 2021, 00:00

  • PCV9 Budget IMPACT Analysis of Vericiguat for the Treatment of Chronic Heart Failure with Reduced Ejection Fraction Following a Worsening Heart Failure Event in the United States

    Jun 1, 2021, 00:00

  • PDG36 Predicting Opioid Use Disorder Using Machine Learning Methodologies

    Jun 1, 2021, 00:00

  • PND58 Health-Related Quality of Life and Caregiver Burden for Caregivers of Individuals with Neurogenic Orthostatic Hypotension

    Jun 1, 2021, 00:00

  • Medical Devices - Patient-Centered Research

    Jun 1, 2021, 00:00

  • PND4 Real World Evidence to Support the Clinical Effectiveness of Multiple Sclerosis Therapies: A US Perspective

    Jun 1, 2021, 00:00

  • PMU19 Comparison of Burden of Hospitalizations in Rheumatoid Arthritis (RA), Crohns Disease (CD) and Ulcerative Colitis (CD) Patients Insured By Medicaid: A Propensity Score Matched Analysis of in-Patient Claims Database

    Jun 1, 2021, 00:00

  • PCN40 Economic and Clinical Burdens of Recurrence Following Nephrectomy for Intermediate-High or High-Risk Renal Cell Carcinoma (RCC): A Retrospective Administrative Claims Analysis

    Jun 1, 2021, 00:00

  • PCN170 Can Early U.S. Adoption of Cancer Drugs Inform HTA Decision-Making?

    Jun 1, 2021, 00:00

  • PCN11 The potential long-term comparative effectiveness of larotrectinib vs. lenvatinib or sorafenib for treatment of NTRK fusion-positive metastatic thyroid cancer

    Jun 1, 2021, 00:00

  • PND21 A Tool Proposal For Measuring Costs Using Time-Driven Activity-Based Costing For The Ischemic Stroke Care Pathway

    Jun 1, 2021, 00:00

  • PMH53 A Machine Learning Approach to Understanding How Patient Engagement with a Prescription Digital Therapeutic Relates to Healthcare Resource Utilization in Opioid Use Disorder

    Jun 1, 2021, 00:00

  • RE3 Expectations Versus Reality: How Real-World Data Fits into Budget Impact Analyses

    Jun 1, 2021, 00:00

  • PIN53 Factors that Predispose Individuals to Influenza Virus Infections: A Claims-Based Case-Control Study

    Jun 1, 2021, 00:00

  • PRS19 Trends in Diagnostic Prevalence, Treatment Patterns, and Healthcare Resource Utilization of Adult Patients with Food Allergies in the United States, 2008-2018

    Jun 1, 2021, 00:00

  • PCN125 Waste of Resources in Cervical and Breast Cancer Screening in JAPAN

    Jun 1, 2021, 00:00

  • PMU62 Improved Quality of Life in Children With Progressive Familial Intrahepatic Cholestasis Following 24 Weeks of Treatment With Odevixibat, an Ileal Bile Acid Transporter Inhibitor: Results From the Phase 3 PEDFIC 1 Study

    Jun 1, 2021, 00:00

  • Cost-Effectiveness Modeling of Surgery Plus Adjuvant Endocrine Therapy Versus Primary Endocrine Therapy Alone in UK Women Aged 70 and Over With Early Breast Cancer

    Jun 1, 2021, 00:00

  • Cancer - Epidemiology Public Health

    Jun 1, 2021, 00:00

  • PMU48 The IMPACT of COVID-19 on European Health Technology Assessments

    Jun 1, 2021, 00:00

  • PND30 Resource Use at Different Levels of Severity of Parkinson's Disease in a Swedish Setting

    Jun 1, 2021, 00:00

  • Urinary/Kidney Disorders - Health Service Delivery Process of Care

    Jun 1, 2021, 00:00

  • PRS27 A Systematic Review on the Impact of Digital Health Technologies in Latent Tuberculosis Infection Management

    Jun 1, 2021, 00:00

  • PND35 Modeling The Economic Impact Of Incorporating AbobotulinumtoxinA Into An Institutional Formulary For FDA-Approved Indications

    Jun 1, 2021, 00:00

  • Surgery - Medical Technologies

    Jun 1, 2021, 00:00

  • RE4 The IMPACT of Reimbursement for NON-Face-to-Face Chronic Care Management on Health Outcomes and Health Care Utilization Among Patients with Type 2 Diabetes in Louisiana

    Jun 1, 2021, 00:00

  • PND31 Comparison of Burden of Hospitalizations in Epilepsy, Migraine and Sleep Disorders: A Propensity Score Matched Analysis of In-Patient Claims Database

    Jun 1, 2021, 00:00

  • PMH13 Healthcare Resource Utilization and Costs before and after Long-Acting Injectable Antipsychotic (LAI) Use in Commercially Insured Young Adults with Schizophrenia

    Jun 1, 2021, 00:00

  • Copyright/Subscription

    Jun 1, 2021, 00:00

  • PCV34 Cost-Offset Analysis of Dapagliflozin in Treating Heart Failure with Reduced Ejection Fraction (HFREF) in China

    Jun 1, 2021, 00:00

  • PND26 The Cost-Effectiveness of Fremanezumab in Patients with Migraine Who Have Failed Two or More Previous Migraine Preventive Therapies From a UK Healthcare System Perspective

    Jun 1, 2021, 00:00

  • PMH23 Epidemiology of Acute Agitation Secondary to Schizophrenia and/or Bipolar Disorder in Patients Presenting to Emergency Departments, a Systematic Literature Review

    Jun 1, 2021, 00:00

  • PMS25 Patient-Reported Outcome Labeling for Rheumatoid Arthritis Drugs Approved in the United States: 2010-2019

    Jun 1, 2021, 00:00

  • PCN75 Cost-Minimization and Budget Impact Analysis of Venetoclax plus Obinutuzumab versus Ibrutinib in High-Risk Patients with Untreated Chronic Lymphocytic Leukemia in the Brazilian Unified Health System (SUS)

    Jun 1, 2021, 00:00

  • PMH11 Differences in Healthcare Expenditures of Older United States Adults with Self-Reported PAIN between Mental Health Status

    Jun 1, 2021, 00:00

  • PCN156 Real-World Non-Persistence with Oral Multiple Myeloma Treatments: A Comparative Analysis of Methodologies Using Claims Data

    Jun 1, 2021, 00:00

  • PIH34 Assessing the Understandability and Importance of Patient Reported Outcomes Impacting Adherence and Outcomes of a NON-Hormonal Vaginal Microbicide to Prevent and Protect Against Chlamydia Trachomatis (CT) and Neisseria Gonorrhoeae (GC ...

    Jun 1, 2021, 00:00

  • PBI2 Real-World Evaluation of Biosimilar Bevacizumab-awwb versus Reference Bevacizumab in Patients with Advanced Non-Squamous Non-Small Cell Lung Cancer in a U.S. Integrated Healthcare Delivery System: 6-Month Interim Analysis

    Jun 1, 2021, 00:00

  • PSS18 Real-World Data Analysis of Dose Escalation and Associated Costs in Biologic Treatment of Psoriasis

    Jun 1, 2021, 00:00

  • PIN61 Switch Patterns Among Patients Claiming Antifungal Therapies for Onychomycosis in Canada

    Jun 1, 2021, 00:00

  • PCN101 Real-World Economic Outcomes of First-Line (1L) Ibrutinib Treatment in Patients With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL)

    Jun 1, 2021, 00:00

  • PNS8 Evaluating Social Media as a Data Source for Patient Experience Measures: A Study Protocol

    Jun 1, 2021, 00:00

  • Mental Health - Epidemiology Public Health

    Jun 1, 2021, 00:00

  • PRS17 Economic Impact of COVID-19 Lockdown on Households in Nigeria

    Jun 1, 2021, 00:00

  • PIN72 Understanding Patient Experiences with Chronic Hepatitis B Virus (cHBV) and its Treatments

    Jun 1, 2021, 00:00

  • PMH26 Early Impact of COVID-19 Pandemic on Antipsychotic Medication Use Among Patients with Schizophrenia

    Jun 1, 2021, 00:00

  • PNS75 The Evolution of Payer Perceptions of Icer

    Jun 1, 2021, 00:00

  • PMH20 Antimuscarinic Prescribing Cascade with Acetylcholinesterase Inhibitor Use Among a National Cohort of Older Adults with Alzheimer's Disease

    Jun 1, 2021, 00:00

  • PCN57 Cost-Effectiveness of Venetoclax in Combination with Obinutuzumab in First LINE Chronic Lymphocytic Leukemia in Colombia

    Jun 1, 2021, 00:00

  • PMH8 Projecting the Economic Outcomes of Switching Patients with Schizophrenia from Oral Atypical Antipsychotics to Once-Monthly Paliperidone Palmitate and Once-Every-Three-Months Paliperidone Palmitate

    Jun 1, 2021, 00:00

  • PNS7 Ongoing SLRs When Considering HTA Submissions: Rewards and Avoidable Pitfalls

    Jun 1, 2021, 00:00

  • Economic Evaluation in Oncology Studies

    Jun 1, 2021, 00:00

  • PDB26 Applying the Stages of Implementation Completion (SIC) Framework Retrospectively to a Community Pharmacy Clinical Intervention Implementation Project for Scaling up Future Success

    Jun 1, 2021, 00:00

  • PCN142 Patient and Caregiver Preferences in Treatment Decision Making in Multiple Myeloma — Results of a Targeted Literature Review

    Jun 1, 2021, 00:00

  • PCN181 Real-World Evidence (RWE) in Reimbursement, Pricing, and Health Technology Assessment (HTA) in ASIA. How CAN Rwe Supplement Trial DATA in Oncology Indications in a Premarketing Setting?

    Jun 1, 2021, 00:00

  • Drugs Process of Care

    Jun 1, 2021, 00:00

  • PND34 Healthcare Utilization and Costs at End-of-Life Among US Medicaid Beneficiaries with Huntington's Disease

    Jun 1, 2021, 00:00

  • PCN70 Healthcare Resource Utilization and Costs Among Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Anaplastic Lymphoma Kinase (ALK) Inhibitors

    Jun 1, 2021, 00:00

  • PCN84 Comparing the Downstream Costs and Healthcare Utilization Associated with the Use of Low-dose Computed Tomography (LDCT) in Lung Cancer Screening in Patients with and without AlzheimerÂ’s Disease and Related Dementias (ADRD)

    Jun 1, 2021, 00:00

  • PRO26 Cost of illness of Sickle Cell Disease in the US, Payer's Perspective: (CRESCENT).

    Jun 1, 2021, 00:00

  • PSU21 Health Resource Utilization and Costs of Rectal Cancer Surgery in Korea

    Jun 1, 2021, 00:00

  • PCN180 Is the Cancer Drugs Fund Functioning As Anticipated?

    Jun 1, 2021, 00:00

  • PDB29 Medication Non-Adherence and Health Literacy Among Medicare Beneficiaries with Type 2 Diabetes

    Jun 1, 2021, 00:00

  • PPM6 Evaluating an Artificial Intelligence Powered Medication Adherence Program's Targeting by Patients' Socially Vulnerability

    Jun 1, 2021, 00:00

  • PND69 Absence Benefit Utilization, Duration of Leaves, and Payments Vary By Benefit and over Time for Short- and Long-Term Disability and Workers' Compensation for Employees with Headaches and Migraines in the United States

    Jun 1, 2021, 00:00

  • PCN153 PhysiciansÂ’ Perceptions and Use of IDH1/2 Mutational Testing and Treatment Selection among Patients with Relapsed or Refractory Acute Myeloid Leukemia in Routine Clinical Practice

    Jun 1, 2021, 00:00

  • PCN240 Healthcare Resource Utilization Associated with Disease Recurrence Among Surgically-Treated Patients with Triple-Negative Breast Cancer

    Jun 1, 2021, 00:00

  • RW3 Quantitative Bias Analysis (QBA) for Comparative Effectiveness of Alectinib versus Ceritinib in Non-Small Cell Lung Cancer (NSCLC)

    Jun 1, 2021, 00:00

  • PRO64 Psychometric Validation of the Brief Fatigue Inventory (BFI) and Brief Pain Inventory Short-Form (BPI-SF) in Tumor-Induced Osteomalacia (TIO)

    Jun 1, 2021, 00:00

  • PCV3 Risk of Obstructive Sleep Apnea in Adults with Treatment Resistant Hypertension: A Population-Based Cohort Study

    Jun 1, 2021, 00:00

  • Sensory System Disorders - Economic Evaluation

    Jun 1, 2021, 00:00

  • PCV15 Cost-Effectiveness of Screening for and Treating Masked Hypertension with out-of-Office Blood Pressure Monitoring

    Jun 1, 2021, 00:00

  • PNS49 Are Multiple Brands Used to Charge Higher Prices for Orphan Drug Designations in the US?

    Jun 1, 2021, 00:00

  • PIH5 Healthcare Resource Utilization Associated with Prematurity: An Analysis of US Medicaid Data

    Jun 1, 2021, 00:00

  • PCN223 Recommendations For The Collection Of Patient-Reported Outcomes (PRO) Data In The Post-Progression And Post-Treatment Setting Following Oncology Clinical Trials

    Jun 1, 2021, 00:00

  • PCN224 Incorporating a Patient-Reported Symptom Burden Tool in Cancer Care Settings

    Jun 1, 2021, 00:00

  • PND37 Cost-Effectiveness of BoNT-A Products for Treatment of Pediatric Spasticity in the United Kingdom

    Jun 1, 2021, 00:00

  • PCN246 Trends in Prevalence, Treatment Patterns, Myelosuppression, and Burden on the Healthcare System Among Patients with Small Cell Lung Cancer: A SEER-Medicare Analysis

    Jun 1, 2021, 00:00

  • Surgery - Economic Evaluation

    Jun 1, 2021, 00:00

  • Expedited Partner Therapy for Sexually Transmitted Infections in Minnesota: A Mixed-Methods Review of Current Practices and Barriers to Implementation

    Jun 1, 2021, 00:00

  • Infectious Diseases - Health Service Delivery Process of Care

    Jun 1, 2021, 00:00

  • Gastrointestinal Disorders - Health Service Delivery Process of Care

    Jun 1, 2021, 00:00

  • Reviewer Acknowledgement

    Jun 1, 2021, 00:00

  • Comparative Effectiveness Studies

    Jun 1, 2021, 00:00

  • PBI7 Cost-Effectiveness Analysis of Adalimumab Biosimilar Compared to Delayed Biologic Treatment Initiation in Patients with Rheumatoid Arthritis in Germany

    Jun 1, 2021, 00:00

  • PIN15 Real-World Healthcare Costs of Patients Receiving Dolutegravir/Lamivudine and Other Single Tablet Regimens for the Treatment of HIV-1 in the US

    Jun 1, 2021, 00:00

  • Valuing Cures: Not If, But When? [Editor's Choice]

    Jun 1, 2021, 00:00

  • PMH9 Economic Burden of Major Depressive Disorder with Acute Suicidal Ideation or Behavior in the United States

    Jun 1, 2021, 00:00

  • PDG30 A Study on Adverse Drug Reaction Related Hospital Admissions of a Tertiary Care Hospital in South India

    Jun 1, 2021, 00:00

  • PCN3 Changes in Transfusion Burden (TB), Hemoglobin (Hb), Serum Ferritin (SF), and Iron Chelation Therapy (ICT) Use in Patients With Lower-Risk Myelodysplastic Syndromes With Ring Sideroblasts Treated With Luspatercept From the MEDALIST Stu ...

    Jun 1, 2021, 00:00

  • Surgery - Health Service Delivery Process of Care

    Jun 1, 2021, 00:00

  • PSU3 The Impact of Operative Approach on Postoperative Outcomes and Health Care Utilization Following Colectomy

    Jun 1, 2021, 00:00

  • PSY5 Comorbidity Related Excess Healthcare Expenditures Among Adults with Psoriasis in the United States: A Propensity Score Matched Analysis

    Jun 1, 2021, 00:00

  • PCV23 Cost-Effectiveness of Dual Versus Triple Antithrombotic Therapy in Atrial Fibrillation and Recent PCI

    Jun 1, 2021, 00:00

  • PMD21 The Association of Major Adverse LIMB Events and Combination Stent and Atherectomy in Patients Undergoing Revascularization for Lower Extremity Peripheral Artery Disease

    Jun 1, 2021, 00:00

  • PCN126 Treatment Pattern and Cost Estimation of Melanoma in Brazilian Public Healthcare System

    Jun 1, 2021, 00:00

  • PNS41 Estimating Administrative Costs Linked to Medical Devices Recalls from the Perspective of the Healthcare Provider

    Jun 1, 2021, 00:00

  • PRO14 Healthcare Resource Utilisation and Costs Saved with Earlier Diagnosis of Behcets Disease: Using UK Primary Care Electronic Health Records

    Jun 1, 2021, 00:00

  • Biologics/Biosimilars/Regenerative Medicine - Economic Evaluation

    Jun 1, 2021, 00:00

  • Biologics/Biosimilars/Regenerative Medicine - Real World Data Information Systems

    Jun 1, 2021, 00:00

  • PRS28 A Scoping Review of Consequences of Untreated Stroke: Economic Burden Due to COVID-19?

    Jun 1, 2021, 00:00

  • PMH6 Healthcare Costs Increase Substantially Following Adjunctive Therapy Among MDD Patients on Antidepressant Monotherapy

    Jun 1, 2021, 00:00

  • Biologics/Biosimilars/Regenerative Medicine - Patient-Centered Research

    Jun 1, 2021, 00:00

  • PDG40 Assessing the Tuscany Region Response to COVID-19 Lockdown in NON-Hospital Supply of Antidiabetic Drugs: An Interrupted Time Series Analysis

    Jun 1, 2021, 00:00

  • Personalized Information Systems

    Jun 1, 2021, 00:00

  • PCN66 A Systematic Literature Review of the Economic Evaluations of Different Treatments in Patients with Chronic Myeloid Leukemia

    Jun 1, 2021, 00:00

  • EM3 Robustness of External Control Arm: WHEN to Use Them

    Jun 1, 2021, 00:00

  • PNS70 Societal Cost Savings Are Often Not Considered in NICE Decision Making

    Jun 1, 2021, 00:00

  • PCN123 Hospital Admissions Associated with Cancer Pain and Dementia in Older Adults

    Jun 1, 2021, 00:00

  • Drugs Generics - Economic Evaluation

    Jun 1, 2021, 00:00

  • PMH36 Think-Aloud Interviews in Health-Related Resource-Use Research: Application in the PECUNIA Project

    Jun 1, 2021, 00:00

  • PCN222 Health Related Quality of Life (HRQoL) Review in Patients with Ovarian Cancer: A Systematic Literature Review (SLR)

    Jun 1, 2021, 00:00

  • PND70 Procedure Coding Versus Pharmacy-Dispensing Claims for Assessing Steroid Use in Patients with Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) and Primary Immunodeficiency Diseases (PIDD)

    Jun 1, 2021, 00:00

  • No Specific Disease - Clinical Outcomes

    Jun 1, 2021, 00:00

  • PCN198 Statistical Methods for Pantumor Analysis: Models to Account for Tumor-Level Heterogeneity

    Jun 1, 2021, 00:00

  • PIN55 Strategies, Ministers of Health and New Regulations: Did We Win or Were We Won By the COVID-19 Pandemic in Brazil?

    Jun 1, 2021, 00:00

  • PB2 Real-World Adherence to Single-Inhaler Fluticasone Furoate/Umeclidinium/Vilanterol Versus Multiple-Inhaler Triple Therapy Among Asthma Patients in the US

    Jun 1, 2021, 00:00

  • Diabetes/Endocrine/Metabolic Disorders - Economic Evaluation

    Jun 1, 2021, 00:00

  • PPM5 The Application of Shared Decision Making in the Chronic Non-Cancer Pain Management: A Systematic Review

    Jun 1, 2021, 00:00

  • PDB45 Continuous Glucose Monitoring (CGM) Trends Among US Adults with Type I Diabetes in National Health and Wellness Survey (NHWS)

    Jun 1, 2021, 00:00

  • PCN33 Real-World Progression-Free Survival by Timing of Molecular Profiling Testing Among Metastatic Non-Small Cell Lung Cancer Patients in a Community Setting

    Jun 1, 2021, 00:00

  • Veterinary Medicine - Patient-Centered Research

    Jun 1, 2021, 00:00

  • PMH3 Effects of Antidepressants on Health-Related Quality of Life in Patients with Major Depressive Disorder; A Secondary Analysis Using Perform-J Study

    Jun 1, 2021, 00:00

  • PNS59 Current Utilization and Perceptions of Value Assessment Frameworks Among United States Payers

    Jun 1, 2021, 00:00

  • PMS32 Prediction Models for Surgical Complications Following Total Knee Arthroplasty: Optum PAN-Therapeutic Electronic Health Records

    Jun 1, 2021, 00:00

  • PMD7 Budget Impact Analysis of Transcutaneous Afferent Patterned Stimulation Therapy for the Treatment of Essential Tremor in the United States

    Jun 1, 2021, 00:00

  • PCN5 EARLY-Onset Colorectal Cancer in the United States: A Narrative Review of the Evidence

    Jun 1, 2021, 00:00

  • PIH19 Dosing and Safety of Medical Cannabis in Children: Preliminary Findings from a Living Systematic Review

    Jun 1, 2021, 00:00

  • SM2 The Consequences of Greater Net Price Transparency for Innovative Medicines in Europe: Insights from a Multi-Agent Simulation Model

    Jun 1, 2021, 00:00

  • PNS69 Burnout Syndrome Prevention In Nursing At Pandemic (Covid-19): A Literature Review

    Jun 1, 2021, 00:00

  • PCN249 Real World Treatment Patterns of Patients with Ovarian Cancer: Analysis of Targeted Therapies in the French National Claims Data

    Jun 1, 2021, 00:00

  • PMU27 Association of Osteoarthritis to Incident Cancer among Adults in the United States

    Jun 1, 2021, 00:00

  • PSY8 Calculating Indirect Costs Associated with Moderate and Severe Psoriasis in Russia

    Jun 1, 2021, 00:00

  • PCN129 Opioid Utilization in Cancer Survivors: A Systematic Literature Review

    Jun 1, 2021, 00:00

  • PCV28 Cost-effectiveness Analysis Of Viscoelastic Point-Of-Care Testing Versus Standard Laboratory Tests For Guiding Transfusion Therapy In Brazilian Patients Who Underwent Complex Cardiac Surgery

    Jun 1, 2021, 00:00

  • Systemic Disorders/Conditions - Health Service Delivery Process of Care

    Jun 1, 2021, 00:00

  • PNS109 Reducing the Racial/Ethnic Disparities in Personal Health Record (PHR) Adoption in the US

    Jun 1, 2021, 00:00

  • PCV13 A Cost Effectiveness Study of Percutaneous Coronary Intervention Versus Coronary Artery Bypass Grafting in Egypt for Patients with Previously Untreated Three-Vessel or Left MAIN Coronary Artery Disease: Markov MODEL.

    Jun 1, 2021, 00:00

  • PRS7 Characteristics, Cost and Health Care Resource Use in a Population of Medicare Fee-for-Service (FFS) Patients with Chronic Obstructive Pulmonary Disease (COPD) Who Also Experience Pneumonia

    Jun 1, 2021, 00:00

  • PNS66 Stated Importance Versus Actual Impact: An Evaluation of HTA Practices to Incorporate Patient Perspectives in Value Assessments

    Jun 1, 2021, 00:00

  • Injury Trauma - Clinical Outcomes

    Jun 1, 2021, 00:00
  • «
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46 (current)
  • 47
  • 48
  • 49
  • 50
  • »